Ablating CAR and Integrin Binding in Adenovirus Vectors Reduces Nontarget Organ Transduction and Permits Sustained Bloodstream Persistence Following Intraperitoneal Administration-Reference-Cited by-同舟云学术

Ablating CAR and Integrin Binding in Adenovirus Vectors Reduces Nontarget Organ Transduction and Permits Sustained Bloodstream Persistence Following Intraperitoneal Administration

Published:2004-02 Issue:2 Volume:9 Page:218-230
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Akiyama Masaki,Thorne Stephen,Kirn David,Roelvink Peter W,Einfeld David A,King C.Richter,Wickham Thomas J

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference71 articles.

1. Gene therapy for ovarian cancer;Wolf;Int. J. Oncol.,2002

2. Treatment of ovarian cancer with a tropism modified oncolytic adenovirus;Bauerschmitz;Cancer Res.,2002

3. Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status;Heise;Gene Ther.,2000

4. Targeted tumor killing via an intracellular antibody against erbB-2;Deshane;J. Clin. Invest.,1995

5. Adenovirus-mediated soluble flt-1 gene therapy for ovarian carcinoma;Mahasreshti;Clin. Cancer Res.,2001

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrin-Targeting Strategies for Adenovirus Gene Therapy;Viruses;2024-05-13

2. Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma;Nature Communications;2023-07-20

3. Rapid generation of a mouse model for evaluating on-target normal tissue toxicity of human CAR-T cells using replication-defective recombinant adenovirus;Journal of Advanced Research;2023-05

4. Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy;Frontiers in Pharmacology;2022-12-08

5. Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer;Cancer Gene Therapy;2020-09-19